Banque Cantonale Vaudoise’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.69M | Buy |
10,529
+231
| +2% | +$103K | 0.19% | 99 |
|
|
2025
Q1 | $4.99M | Buy |
+10,298
| New | +$4.99M | 0.22% | 86 |
|
|
2024
Q3 | $5.2M | Buy |
11,182
+8,720
| +354% | +$4.06M | 0.21% | 107 |
|
|
2024
Q2 | $1.15M | Buy |
2,462
+1,256
| +104% | +$589K | 0.05% | 324 |
|
|
2024
Q1 | $504K | Sell |
1,206
-4,457
| -79% | -$1.86M | 0.02% | 426 |
|
|
2023
Q4 | $2.3M | Sell |
5,663
-1,402
| -20% | -$570K | 0.1% | 211 |
|
|
2023
Q3 | $2.46M | Buy |
7,065
+861
| +14% | +$299K | 0.12% | 135 |
|
|
2023
Q2 | $2.18M | Sell |
6,204
-555
| -8% | -$195K | 0.1% | 176 |
|
|
2023
Q1 | $2.13M | Buy |
6,759
+1,600
| +31% | +$504K | 0.1% | 193 |
|
|
2022
Q4 | $1.49M | Sell |
5,159
-2,819
| -35% | -$814K | 0.08% | 236 |
|
|
2022
Q3 | $2.31M | Sell |
7,978
-478
| -6% | -$138K | 0.13% | 149 |
|
|
2022
Q2 | $2.38M | Buy |
8,456
+320
| +4% | +$90.1K | 0.12% | 152 |
|
|
2022
Q1 | $2.12M | Buy |
8,136
+1,955
| +32% | +$510K | 0.09% | 216 |
|
|
2021
Q4 | $1.36M | Sell |
6,181
-8,088
| -57% | -$1.78M | 0.05% | 343 |
|
|
2021
Q3 | $2.59M | Sell |
14,269
-3,042
| -18% | -$552K | 0.11% | 178 |
|
|
2021
Q2 | $3.49M | Buy |
17,311
+4,930
| +40% | +$994K | 0.16% | 136 |
|
|
2021
Q1 | $2.66M | Sell |
12,381
-239
| -2% | -$51.3K | 0.14% | 153 |
|
|
2020
Q4 | $2.98M | Buy |
12,620
+296
| +2% | +$69.9K | 0.17% | 128 |
|
|
2020
Q3 | $3.35M | Sell |
12,324
-7,197
| -37% | -$1.96M | 0.22% | 98 |
|
|
2020
Q2 | $5.67M | Buy |
19,521
+9,673
| +98% | +$2.81M | 0.41% | 47 |
|
|
2020
Q1 | $2.34M | Sell |
9,848
-60
| -0.6% | -$14.3K | 0.2% | 102 |
|
|
2019
Q4 | $2.17M | Buy |
+9,908
| New | +$2.17M | 0.15% | 151 |
|